StockStory
1 Russell 2000 Stock to Keep an Eye On and 2 Facing Challenges
➖
AI Sentiment
Neutral
4/10
- Home
- CLOV
as of 02-24-2026 9:38am EST
$1.98
$0.00
-0.25%
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.
| Founded: | 2014 | Country: | United States |
| Employees: | N/A | City: | JERSEY CITY |
| Market Cap: | 1.0B | IPO Year: | 2020 |
| Target Price: | $3.35 | AVG Volume (30 days): | 5.8M |
| Analyst Decision: | Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.44 | EPS Growth: | 38.03 |
| 52 Week Low/High: | $1.95 - $4.52 | Next Earning Date: | 01-01-0001 |
| Revenue: | $1,371,131,000 | Revenue Growth: | -32.58% |
| Revenue Growth (this year): | 41.68% | Revenue Growth (next year): | 43.92% |
| P/E Ratio: | -4.50 | Index: | N/A |
| Free Cash Flow: | 33.3M | FCF Growth: | N/A |
Stock Insider Trading Activity of Clover Health Investments Corp. (CLOV)
Reynoso Jamie L.
Sell
CEO, Medicare Advantage
CLOV Jan 20, 2026
Avg Cost/Share
$2.58
Shares
4,597
Total Value
$11,860.26
Owned After
2,737,700
SEC Form 4
Reynoso Jamie L.
Sell
CEO, Medicare Advantage
CLOV Jan 7, 2026
Avg Cost/Share
$2.53
Shares
2,102
Total Value
$5,318.06
Owned After
2,737,700
SEC Form 4
Reynoso Jamie L.
Sell
CEO, Medicare Advantage
CLOV Dec 18, 2025
Avg Cost/Share
$2.61
Shares
4,913
Total Value
$12,822.93
Owned After
2,737,700
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Reynoso Jamie L. | CLOV | CEO, Medicare Advantage | Jan 20, 2026 | Sell | $2.58 | 4,597 | $11,860.26 | 2,737,700 | |
| Reynoso Jamie L. | CLOV | CEO, Medicare Advantage | Jan 7, 2026 | Sell | $2.53 | 2,102 | $5,318.06 | 2,737,700 | |
| Reynoso Jamie L. | CLOV | CEO, Medicare Advantage | Dec 18, 2025 | Sell | $2.61 | 4,913 | $12,822.93 | 2,737,700 |
Latest Clover Health Investments Corp. News
CLOV Breaking Stock News: Dive into CLOV Ticker-Specific Updates for Smart Investing
Zacks
iRhythm Holdings, Inc. (IRTC) Q4 Earnings and Revenues Beat Estimates
📈
AI Sentiment
Highly Positive
9/10
Compare CLOV vs Leading Stocks
See how CLOV stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "CLOV Clover Health Investments Corp. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.